item1.txt
1 to such Annual Report on Form 10-K, filed with the SEC on January 25, 2019 (the “2018 10-K”).
In October 2016, the FASB issued ASU 2016-16, Income Taxes (Topic 740), Intra-entity Transfers of an Asset Other than Inventory (“ASU 2016-16”).
Similarly, the purchasing (receiving) entity is required to recognize a deferred tax asset or deferred tax liability, as well as the related deferred tax benefit or expense, upon receipt of the asset.
This ASU provides guidance for the recognition, measurement, presentation, and disclosure of financial assets and liabilities.
The Company plans to adopt the new guidance in the first quarter of fiscal 2020.
At September 28, 2018, the Company had $13.9 million accrued to other long-term liabilities for capital equipment, and $94.1 million accrued to accounts payable for capital equipment.
The impact from the cumulative effect adjustment was not material and comparative information for prior periods has not been adjusted.
As of March 29, 2019, the amount of remaining performance obligation that has not been recognized as revenue is not material.
The contractual maturities of noncurrent available-for-sale marketable securities were due within two years or less.
There were $0.1 million in unrealized gains on municipal bonds at March 29, 2019, and $0.1 million in unrealized losses on municipal bonds at September 28, 2018.
•Level 1 - Quoted prices in active markets for identical assets or liabilities.
•Level 3 - Fair value is derived from valuation techniques in which one or more significant inputs are unobservable, including assumptions and judgments made by the Company.
There have been no transfers between Level 1, 2 or 3 assets or liabilities during the three and six months ended March 29, 2019.
This newly authorized stock repurchase plan replaces in its entirety the January 31, 2018, stock repurchase program.
The repurchase program may be suspended or discontinued at any time.


item2.txt
Our analog semiconductors are connecting people, places, and things spanning a number of new applications within the aerospace, automotive, broadband, cellular infrastructure, connected home, industrial, medical, military, smartphone, tablet and wearable markets.
Gross profit margin decreased to 49.7% of net revenue for the six months ended March 29, 2019, as compared with 50.7% in the corresponding period in fiscal 2018.
The increase in research and development expenses for the three and six months ended March 29, 2019, as compared with the corresponding periods in fiscal 2018, was primarily related to an increase in employee-related compensation expense and product development–related expenses.
The effective tax rates for the three and six months ended March 29, 2019, were 11.4% and 11.8%, respectively, as compared with 5.6% and 48.9% for the three and six months ended March 30, 2018, respectively.
Cash provided by operating activities consists of net income for the period adjusted for certain non-cash items and changes in certain operating assets and liabilities.
Purchases of marketable securities were $166.7 million and sales and maturities of marketable securities were $309.2 million during the six months ended March 29, 2019.
•$133.1 million related to the payment of cash dividends on our common stock.
The decrease resulted from $425.5 million used to repurchase 5.7 million shares of stock, $133.1 million in cash dividend payments, and $226.2 million in capital expenditures, which was partially offset by $741.1 million in cash generated from operations.
Our contractual obligations disclosure in the 2018 10-K has not materially changed since we filed that report.


item3.txt
We are subject to overall financial market risks, such as changes in market liquidity, credit quality, investment risk, interest rate risk, and foreign exchange rate risk as described below.
Our marketable securities consist of short-term and long-term maturity periods between 90 days and two years.


item4.txt
Our management, with the participation of our chief executive officer and chief financial officer, evaluated the effectiveness of our disclosure controls and procedures as of March 29, 2019.


part2.txt
Item 1.
Unregistered Sales of Equity Securities and Use of Proceeds.


